| PERIOD ENDING | 5-Apr-09 | 31-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 8,264,000 | 7,852,000 | 7,140,000 | 7,303,000 | | Cost of Revenue | 6,849,000 | 6,490,000 | 5,793,000 | 5,931,000 | | | Gross Profit | 1,415,000 | 1,362,000 | 1,347,000 | 1,372,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 510,000 | 424,000 | 414,000 | 451,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 905,000 | 938,000 | 933,000 | 921,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | 25,000 | 16,000 | 21,000 | | Earnings Before Interest And Taxes | 911,000 | 963,000 | 949,000 | 942,000 | | Interest Expense | 42,000 | 35,000 | 27,000 | 33,000 | | Income Before Tax | 869,000 | 928,000 | 922,000 | 909,000 | | Income Tax Expense | 276,000 | 298,000 | 288,000 | 268,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 593,000 | 630,000 | 634,000 | 641,000 | | | Non-recurring Events | | Discontinued Operations | (3,000) | (18,000) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 590,000 | 612,000 | 634,000 | 641,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $590,000 | $612,000 | $634,000 | $641,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
